Exploring the inhibitory activity of short-chain phospholipids against amyloid fibrillogenesis of hen egg-white lysozyme

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1811, Issue 5, 2011, Pages 301-313

  Wang, Steven S S ^a   Hung, Ying Tz ^a   Wen, Wen Sing ^a   Lin, Keng Chi ^a   Chen, Geng Yuan ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Amyloid; Fibril; Inhibition; Lysozyme; Phospholipid

Indexed keywords

1,2 DIHEPTANOYL SN GLYCERO 3 PHOSPHOCHOLIN; 1,2 DIHEXANOYL SN GLYCERO 3 PHOSPHOCHOLINE; AMYLOID; EGG WHITE; LYSOZYME; PHOSPHOLIPID; UNCLASSIFIED DRUG; UREA;

ARTICLE; BETA SHEET; CONFORMATIONAL TRANSITION; HEN; HYDROPHOBICITY; LIGHT SCATTERING; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; SIMULATION; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID; ANIMALS; CHICKENS; FEMALE; HUMANS; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; MURAMIDASE; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; PROTEIN DENATURATION; PROTEIN STRUCTURE, SECONDARY; UREA;

EID: 79952706244     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2011.02.003     Document Type: Article

References (81)

1. V.N. Uversky, and A.L. Fink Conformational constraints for amyloid fibrillation: the importance of being unfolded Biochim. Biophys. Acta 1698 2004 131 153 (Pubitemid 38591469)
2. S.S.S. Wang, and T.A. Good An overview of Alzheimer's disease J. Chin. Inst. Chem. Eng. 36 2005 533 559 (Pubitemid 43216438)
3. C.M. Dobson Principles of protein folding, misfolding and aggregation Semin. Cell Dev. Biol. 15 2004 3 16 (Pubitemid 38177363)
4. C.M. Dobson Protein folding and misfolding Nature 426 2003 884 890 (Pubitemid 38056880)
5. P. Kuner, B. Bohrmann, L.O. Tjernberg, J. Naslund, G. Huber, S. Celenk, F. Gruninger-Leitch, J.G. Richards, R. Jakob-Roetne, J.A. Kemp, and C. Nordstedt Controlling polymerization of beta-amyloid and prion-derived peptides with synthetic small molecule ligands J. Biol. Chem. 275 2000 1673 1678 (Pubitemid 30060785)
6. M.W. Cao, Y.C. Han, J.B. Wang, and Y.L. Wang Modulation of fibrillogenesis of amyloid beta(1-40) peptide with cationic gemini surfactant J. Phys. Chem. B 111 2007 13436 13443
7. V. Tougu, A. Karafin, K. Zovo, R.S. Chung, C. Howells, A.K. West, and P. Palumaa Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators J. Neurochem. 110 2009 1784 1795
8. V. Vetri, F. Librizzi, V. Militello, and M. Leone Effects of succinylation on thermal induced amyloid formation in Concanavalin A Eur. Biophys. J. Biophys. Lett. 36 2007 733 741 (Pubitemid 350092524)
9. D.L. Rymer, and T.A. Good The role of G protein activation in the toxicity of amyloidogenic Abeta- (1-40), Abeta-(25-35), and bovine calcitonin J. Biol. Chem. 276 2001 2523 2530
10. R.V. Ward, K.H. Jennings, R. Jepras, W. Neville, D.E. Owen, J. Hawkins, G. Christie, J.B. Davis, A. George, E.H. Karran, and D.R. Howlett Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide Biochem. J. 348 Pt 1 2000 137 144 (Pubitemid 30312141)
11. V. Heiser, E. Scherzinger, A. Boeddrich, E. Nordhoff, R. Lurz, N. Schugardt, H. Lehrach, and E.E. Wanker Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy Proc. Natl Acad. Sci. USA 97 2000 6739 6744 (Pubitemid 30412784)
12. V. Vetri, C. Canale, A. Relini, F. Librizzi, V. Militello, A. Gliozzi, and M. Leone Amyloid fibrils formation and amorphous aggregation in concanavalin A Biophys. Chem. 125 2007 184 190 (Pubitemid 44709396)
13. F. Chiti, and C.M. Dobson Amyloid formation by globular proteins under native conditions Nat. Chem. Biol. 5 2009 15 22
14. A.D. Ferrao-Gonzales, S.O. Souto, J.L. Silva, and D. Foguel The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state Proc. Natl Acad. Sci. USA 97 2000 6445 6450 (Pubitemid 30412733)
15. W. Wang Protein aggregation and its inhibition in biopharmaceutics Int. J. Pharm. 289 2005 1 30 (Pubitemid 40093537)
16. L. Nielsen, S. Frokjaer, J. Brange, V.N. Uversky, and A.L. Fink Probing the mechanism of insulin fibril formation with insulin mutants Biochemistry 40 2001 8397 8409 (Pubitemid 32661900)
17. M.C. Vaney, S. Maignan, M. Ries-Kautt, and A. Ducriux High-resolution structure (1.33 A) of a HEW lysozyme tetragonal crystal grown in the APCF apparatus. Data and structural comparison with a crystal grown under microgravity from SpaceHab-01 mission Acta Crystallogr. D Biol. Crystallogr. 52 1996 505 517 (Pubitemid 126516233)
18. E. Frare, P.P. de Laureto, J. Zurdo, C.M. Dobson, and A. Fontana A highly amyloidogenic region of hen lysozyme J. Mol. Biol. 340 2004 1153 1165 (Pubitemid 38968708)
19. R. Mishra, K. Sorgjerd, S. Nystrom, A. Nordigarden, Y.C. Yu, and P. Hammarstrom Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion J. Mol. Biol. 366 2007 1029 1044 (Pubitemid 46175878)
20. D.R. Booth, M. Sunde, V. Bellotti, C.V. Robinson, W.L. Hutchinson, P.E. Fraser, P.N. Hawkins, C.M. Dobson, S.E. Radford, C.C.F. Blake, and M.B. Pepys Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis Nature 385 1997 787 793 (Pubitemid 27106061)
21. M.B. Pepys, P.N. Hawkins, D.R. Booth, D.M. Vigushin, G.A. Tennent, A.K. Soutar, N. Totty, O. Nguyen, C.C. Blake, and C.J. Terry Human lysozyme gene mutations cause hereditary systemic amyloidosis Nature 362 1993 553 557 (Pubitemid 23113032)
22. D. Morshedi, N. Rezaei-Ghaleh, A. Ebrahim-Habibi, S. Ahmadian, and M. Nemat-Gorgani Inhibition of amyloid fibrillation of lysozyme by indole derivatives-possible mechanism of action FEBS J. 274 2007 6415 6425 (Pubitemid 350215930)
23. S.S.S. Wang, K.N. Liu, and W.H. Lee Effect of curcumin on the amyloid fibrillogenesis of hen egg-white lysozyme Biophys. Chem. 144 2009 78 87
24. L. Nielsen, R. Khurana, A. Coats, S. Frokjaer, J. Brange, S. Vyas, V.N. Uversky, and A.L. Fink Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism Biochemistry 40 2001 6036 6046 (Pubitemid 32466306)
25. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk Measurement of protein using bicinchoninic acid Anal. Biochem. 150 1985 76 85 (Pubitemid 16258399)
26. L. Whitmore, and B.A. Wallace DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data Nucleic Acids Res. 32 2004 W668 W673
27. H. LeVine III Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution Protein Sci. 2 1993 404 410
28. D.P. Hong, A. Ahmad, and A.L. Fink Fibrillation of human insulin A and B chains Biochemistry 45 2006 9342 9353 (Pubitemid 44156398)
29. C.P. Liu, Z.Y. Li, G.C. Huang, S. Perrett, and J.M. Zhou Two distinct intermediates of trigger factor are populated during guanidine denaturation Biochimie 87 2005 1023 1031 (Pubitemid 41377162)
30. A.L. Smoot, M. Panda, B.T. Brazil, A.M. Buckle, A.R. Fersht, and P.M. Horowitz The binding of bis-ANS to the isolated GroEL apical domain fragment induces the formation of a folding intermediate with increased hydrophobic surface not observed in tetradecameric GroEL Biochemistry 40 2001 4484 4492 (Pubitemid 32319594)
31. G.V. Semisotnov, N.A. Rodionova, O.I. Razgulyaev, V.N. Uversky, A.F. Gripas, and R.I. Gilmanshin Study of the "molten globule" intermediate state in protein folding by a hydrophobic fluorescent probe Biopolymers 31 1991 119 128
32. L.H. Dao, H.M. Nguyen, and H.H. Mai A fiber optic turbidity system for in-situ monitoring protein aggregation, nucleation and crystallisation Acta Astronaut. 47 2000 399 409
33. A. Moreno, J. Mas-Oliva, M. Soriano-Garcia, C.O. Salvador, and V.M. Bolanos-Garcia Turbidity as a useful optical parameter to predict protein crystallization by dynamic light scattering J. Mol. Struct. 519 2000 243 256 (Pubitemid 30139814)
34. O.P. Bliznyukov, L.D. Kozmin, L.L. Vysotskaya, A.K. Golenkov, V.M. Tishchenko, M.P. Samoylovich, and V.B. Klimovich Human immunoglobulin light chains lambda form amyloid fibrils and granular aggregates in solution Biochemistry-Moscow 70 2005 458 466 (Pubitemid 40878792)
35. A.K. Thakur, and C.M. Rao UV-light exposed prion protein fails to form amyloid fibrils Plos One 3 2008
36. T.A. Andersson, K.M. Hartonen, and M.L. Riekkola Solubility of acenaphthene, anthracene, and pyrene in water at 50 degrees C to 300 degrees C J. Chem. Eng. Data 50 2005 1177 1183
37. L.Z. Zhu, and C.T. Chiou Water solubility enhancements of pyrene by single and mixed surfactant solutions J. Environ. Sci. 13 2001 491 496 (Pubitemid 33053046)
38. S. Pandey, R.A. Redden, A.E. Hendricks, K.A. Fletcher, and C.P. Palmer Characterization of the solvation environment provided by dilute aqueous solutions of novel siloxane polysoaps using the fluorescence probe pyrene J. Colloid Interface Sci. 262 2003 579 587 (Pubitemid 36627539)
39. A.B. Patel, P. Khumsupan, and V. Narayanaswami Pyrene fluorescence analysis offers new insights into the conformation of the lipoprotein-binding domain of human apolipoprotein E Biochemistry 49 2010 1766 1775
40. J. Aguiar, P. Carpena, J.A. Molina-Bolivar, and C.C. Ruiz On the determination of the critical micelle concentration by the pyrene 1: 3 ratio method J. Colloid Interface Sci. 258 2003 116 122 (Pubitemid 36228364)
41. M.A.D. Silva, D.C. da Silva, V.G. Machado, E. Longhinotti, and V.L.A. Frescura Preferential solvation of a hydrophobic probe in binary mixtures comprised of a nonprotic and a hydroxylic solvent: a view of solute-solvent and solvent-solvent interactions J. Phys. Chem. A 106 2002 8820 8826 (Pubitemid 35382443)
42. L.N. Arnaudov, and R. de Vries Thermally induced fibrillar aggregation of hen egg white lysozyme Biophys. J. 88 2005 515 526 (Pubitemid 40070697)
43. M. Malisauskas, V. Zamotin, J. Jass, W. Noppe, C.M. Dobson, and L.A. Morozova-Roche Amyloid protofilaments from the calcium-binding protein equine lysozyme: formation of ring and linear structures depends on pH and metal ion concentration J. Mol. Biol. 330 2003 879 890
44. S.S.S. Wang, K.N. Liu, B.W. Wang, Effects of dithiothreitol on the amyloid fibrillogenesis of hen egg-white lysozyme, Eur. Biophys. J. Biophys. Lett. 39, 1229-1242.
45. A.F. Robertson, and W.E.M. Lands Metabolism of phospholipids in normal and spherocytic human erythrocytes J. Lipid Res. 5 1964 88 93
46. D. Albert, and C. Anderson Fatty acid composition at the 2-position of ether-linked and diacyl ethanolamine and choline phosphoglycerides of human brain tumors Lipids 12 1977 722 728 (Pubitemid 8215196)
47. E. Malle, E. Schwengerer, F. Paltauf, and A. Hermetter Transfer of pyrene-labelled diacyl-, alkylacyl-, and alkenylacyl-glycerophospholipids from vesicles to human blood platelets Biochim. Biophys. Acta (BBA) - Biomembr. 1189 1994 61 64 (Pubitemid 24029713)
48. T.L. Lin, S.H. Chen, N.E. Gabriel, and M.F. Roberts Small-angle neutron-scattering techniques applied to the study of polydisperse rodlike diheptanoylphosphatidylcholine micelles J. Phys. Chem. 91 1987 406 413
49. M.P. Bennett, and D.C. Mitchell Regulation of membrane proteins by dietary lipids: effects of cholesterol and docosahexaenoic acid acyl chain-containing phospholipids on rhodopsin stability and function Biophys. J. 95 2008 1206 1216
50. K. Shahidullah, and E. London Effect of lipid composition on the topography of membrane-associated hydrophobic helices: stabilization of transmembrane topography by anionic lipids J. Mol. Biol. 379 2008 704 718
51. M.E. Reinau, and D.E. Otzen Stability and structure of the membrane protein transporter Ffh is modulated by substrates and lipids Arch. Biochem. Biophys. 492 2009 48 53
52. D.M. Charbonneau, and H.A. Tajmir-Riahi Study on the interaction of cationic lipids with bovine serum albumin J. Phys. Chem. B 114 2010 1148 1155
53. C.R. Stewart, L.M. Wilson, Q. Zhang, C.L.L. Pham, L.J. Waddington, M.K. Staples, D. Stapleton, J.W. Kelly, and G.J. Howlett Oxidized cholesterol metabolites found in human atherosclerotic lesions promote apolipoprotein C-II amyloid fibril formation Biochemistry 46 2007 5552 5561 (Pubitemid 46717277)
54. T.M. Ryan, G.J. Howlett, and M.F. Bailey Fluorescence detection of a lipid-induced tetrameric intermediate in amyloid fibril formation by Apolipoprotein C-II J. Biol. Chem. 283 2008 35118 35128
55. K. Usui, J.D. Hulleman, J.F. Paulsson, S.J. Siegel, E.T. Powers, and J.W. Kelly Site-specific modification of Alzheimer's peptides by cholesterol oxidation products enhances aggregation energetics and neurotoxicity Proc. Natl Acad. Sci. USA 106 2009 18563 18568
56. C. Cecchi, D. Nichino, M. Zampagni, C. Bernacchioni, E. Evangelisti, A. Pensalfini, G. Liguri, A. Gliozzi, M. Stefani, and A. Relini A protective role for lipid raft cholesterol against amyloid-induced membrane damage in human neuroblastoma cells Biochim. Biophys. Acta 1788 2009 2204 2216
57. C.H. Davis, and M.L. Berkowitz A molecular dynamics study of the early stages of amyloid-beta(1-42) oligomerization: the role of lipid membranes Proteins: Struct., Funct., Bioinf. 78 2010 2533 2545
58. P. Gale The prion/lipid hypothesis - further evidence to support the molecular basis for transmissible spongiform encephalopathy risk assessment J. Appl. Microbiol. 103 2007 2033 2045 (Pubitemid 350191144)
59. S. Yamamoto, J.J. Kazama, I. Narita, H. Naiki, and F. Gejyo Recent progress in understanding dialysis-related amyloidosis Bone 45 2009 S39 S42
60. R. Sabate, and J. Estelrich Stimulatory and inhibitory effects of alkyl bromide surfactants on beta-amyloid fibrillogenesis Langmuir 21 2005 6944 6949 (Pubitemid 41084482)
61. A.A. Moosavi-Movahedi, P. Pirzadeh, S. Hashemnia, S. Ahmadian, B. Hemmateenejad, M. Amani, A.A. Saboury, F. Ahmad, M. Shamsipur, G.H. Hakimelahi, F.Y. Tsai, H.H. Alijanvand, and R. Yousefi Fibril formation of lysozyme upon interaction with sodium dodecyl sulfate at pH 9.2 Colloids Surf. B 60 2007 55 61 (Pubitemid 47307386)
62. M.D.W. Griffin, M.L.Y. Mok, L.M. Wilson, C.L.L. Pham, L.J. Waddington, M.A. Perugini, and G.J. Howlett Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways J. Mol. Biol. 375 2008 240 256 (Pubitemid 350160696)
63. A. Hung, M.D.W. Griffin, G.J. Howlett, and I. Yarovsky Lipids enhance apolipoprotein C-II-derived amyloidogenic peptide oligomerization but inhibit fibril formation J. Phys. Chem. B 113 2009 9447 9453
64. S.S.S. Wang, Y.T. Chen, and S.W. Chou Inhibition of amyloid fibril formation of beta-amyloid peptides via the amphiphilic surfactants Bba-Mol Basis Dis 1741 2005 307 313
65. S.S.S. Wang, K.N. Liu, and T.C. Han Amyloid fibrillation and cytotoxicity of insulin are inhibited by the amphiphilic surfactants Bba-Mol. Basis Dis. 1802 2010 519 530
66. A. Lomakin, D.S. Chung, G.B. Benedek, D.A. Kirschner, and D.B. Teplow On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants Proc. Natl Acad. Sci. USA 93 1996 1125 1129 (Pubitemid 26054370)
67. S.S.S. Wang, P.H. Chen, and Y.T. Hung Effects of p-benzoquinone and melatonin on amyloid fibrillogenesis of hen egg-white lysozyme J. Mol. Catal. B Enzym. 43 2006 49 57
68. M. Sunde, and C.C.F. Blake From the globular to the fibrous state: protein structure and structural conversion in amyloid formation Q. Rev. Biophys. 31 1998 1 39 (Pubitemid 28379176)
69. I.V. Baskakov, and D.W. Bolen The paradox between m values and Delta Cp's for denaturation of ribonuclease T1 with disulfide bonds intact and broken Protein Sci. 8 1999 1314 1319 (Pubitemid 29264962)
70. J.K. Myers, C.N. Pace, and J.M. Scholtz Denaturant M-values and heat-capacity changes-relation to changes in accessible surface-areas of protein unfolding Protein Sci. 4 1995 2138 2148
71. S. Shimizu, and H.S. Chan Origins of protein denatured state compactness and hydrophobic clustering in aqueous urea: inferences from nonpolar potentials of mean force Proteins 49 2002 560 566 (Pubitemid 35388139)
72. B. Ma, and R. Nussinov Molecular dynamics simulations of alanine rich beta-sheet oligomers: insight into amyloid formation Protein Sci. 11 2002 2335 2350
73. C. Wu, Z. Wang, H. Lei, W. Zhang, and Y. Duan Dual binding modes of Congo red to amyloid protofibril surface observed in molecular dynamics simulations J. Am. Chem. Soc. 129 2007 1225 1232 (Pubitemid 46208593)
74. E.T. Powers, and D.L. Powers Mechanisms of protein fibril formation: nucleated polymerization with competing off-pathway aggregation Biophys. J. 94 2008 379 391
75. L.A. Munishkina, E.M. Cooper, V.N. Uversky, and A.L. Fink The effect of macromolecular crowding on protein aggregation and amyloid fibril formation J. Mol. Recognit. 17 2004 456 464 (Pubitemid 39218989)
76. J.S. Pedersen, G. Christensen, and D.E. Otzen Modulation of S6 fibrillation by unfolding rates and gatekeeper residues J. Mol. Biol. 341 2004 575 588 (Pubitemid 38987789)
77. V.N. Uversky, and A.L. Fink Conformational constraints for amyloid fibrillation: the importance of being unfolded BBA-Proteins Proteomics 1698 2004 131 153 (Pubitemid 38591469)
78. S. Ohnishi, and K. Takano Amyloid fibrils from the viewpoint of protein folding Cell. Mol. Life Sci. 61 2004 511 524 (Pubitemid 38372906)
79. R. Khurana, C. Ionescu-Zanetti, M. Pope, J. Li, L. Nielson, M. Ramirez-Alvarado, L. Regan, A.L. Fink, and S.A. Carter A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy Biophys. J. 85 2003 1135 1144 (Pubitemid 36909675)
80. H. Yagi, E. Kusaka, K. Hongo, T. Mizobata, and Y. Kawata Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins-implications for the mechanism of transmissible conformational diseases J. Biol. Chem. 280 2005 38609 38616 (Pubitemid 43853762)
81. V.N. Uversky, G. Yamin, P.O. Souillac, J. Goers, C.B. Glaser, and A.L. Fink Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro FEBS Lett. 517 2002 239 244 (Pubitemid 34327667)